SCHEMBL27913613

SCHEMBL27913613

CCOC(=O)c1c(O)c(C2CCCCC2)nn(Cc2ccccc2CN)c1=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 5/20 0.39
ADORA3 P0DMS8 3/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
EPHX2 P34913 1/20 0.37
RECQL P46063 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ADORA1 P30542 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ELANE P08246 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OGFRL1 Q5TC84 1/20 0.35
ADORA2A P29274 1/20 0.35
GRK6 P43250 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3853251 0.90 ALDH1A1 (0.42) KDM4EALDH1A1ADORA3LMNARECQL
SCHEMBL3849583 0.89 SMN1; SMN2 (0.48) KDM4EALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL3848493 0.89 ALDH1A1 (0.43) KDM4EALDH1A1ADORA3LMNAMAPK1
SCHEMBL3854700 0.86 MAPK1 (0.50) KDM4EALDH1A1ADORA3MAPK1SMN1; SMN2
SCHEMBL27895958 0.79 KDM4E (0.47) KDM4EALDH1A1LMNAMAPK1RECQL
SCHEMBL3846045 0.79 ALDH1A1 (0.45) KDM4EALDH1A1ADORA3MAPK1ADORA1
SCHEMBL3849218 0.79 SMN1; SMN2 (0.45) KDM4EALDH1A1ADORA3LMNAMAPK1
SCHEMBL3849163 0.79 PTGDR2 (0.50) KDM4EALDH1A1ADORA3MAPK1ADORA1
SCHEMBL4575033 0.76 ALDH1A1 (0.36) KDM4EALDH1A1ADORA3LMNAOPRM1
SCHEMBL3845837 0.74 ALDH1A1 (0.43) KDM4EALDH1A1ADORA3LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101626685-B N-substituted glycine derivatives: hydroxylase inhibitors SMITHKLINE BEECHAM CORP 2013-03-13 CN disclosed